Study of AZD8931 in Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2012

Conditions

Advanced Solid Malignancies

Interventions

DRUG

AZD8931

Tolerability and Pharmacokinetics of AZD8931 in Patients with Advanced Solid Malignancies.

Trial Locations (3)

Research Site, Berlin

Research Site, Moscow

Research Site, Saint Petersburg